---
title: "Pharmacogenomics Informed Medications Management Service"
ocid: "ocds-h6vhtk-02fad8"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02fad8"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-02fad8.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-02fad8.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")"
published: "2024-09-03"
---

# Pharmacogenomics Informed Medications Management Service

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")  
Current stage: Award  
OCID: ocds-h6vhtk-02fad8

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02fad8)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-02fad8.json)

## Summary

The Common Services Agency, more commonly known as NHS National Services Scotland (NSS), had initiated a procurement process titled "Pharmacogenomics Informed Medications Management Service" under the CPV classification for pharmacy services. The procurement, conducted within the "services" category, aimed to secure an Innovation Partner to develop an integrated Pharmacogenomics and Pharmaceutical Clinical Decision Support Service for NHS Scotland. The project, slated for two phases, includes a patient trial in Greater Glasgow and Clyde and potentially a wider rollout across NHS Scotland if the initial phase proves viable. The procurement commenced with a selective method, initially taken at the tender stage in November 2021 with submissions closing in January 2022. Despite these efforts, the contract status is currently marked as cancelled, and the procurement was lastly updated on 3rd September 2024.

This procurement offered significant potential for business growth, particularly for companies specialising in pharmacogenomics, pharmaceutical clinical decision support systems, and integration of medical technology into electronic health records. It was particularly suited for firms capable of meeting rigorous regulatory requirements, managing innovative projects, and providing educational programmes to enhance clinician and public understanding of pharmacogenomics. The project’s focus on patient safety and tailored medication regimes underscored its importance. The estimated contract value was £66 million with robust criteria favouring quality and performance, making it an attractive opportunity for highly qualified and innovative businesses in the pharmaceutical and healthcare technology sectors.

## Notice

This requirement is to identify an Innovation Partner who will develop an integrated Pharmacogenomics and Pharmaceutical Clinical Decision Support Service for NHS Scotland which will safely identify patients at greatest risk of harm from multiple medication and produce an efficient, safe and effective medication regime that is tailored to meet their changing needs.

### Lot Information

Lot 1

The Authority is procuring the provision of an integrated pharmacogenomics and pharmaceutical clinical decision support service which will safely identify patients at greatest risk of harm from multiple medication and produce an efficient, safe and effective medication regime that is tailored to meet the patient's changing needs. The developed solution will need to comply with any and all regulatory requirements. The solution to be developed by the tenderers should aim to provide enabling tools to implement pharmacogenetic testing and integration into electronic health records and clinical decision support systems, comprising, but not limited to: - Pharmacogenetic panel - Clinical decision support system that is approved and regulated in line with the medical device regulations and any subsequent requirements that may be produced for operating within the United Kingdom. Tenderers will be responsible for registering and managing the developed software as a medical device (SAMD) for the duration of the awarded framework agreement and for elements of Phase 2c of the Procurement (please see the Invitation to Tender - Introductory Information document for details of the Procurement phases) as required and deemed by the Authority (if available). - Technology to integrate into primary and secondary care electronic health record systems, and the resource to support the integration into each of the Authority and Participating Authorities systems as outlined in the ITT and Associated Documentation. - An education programme for the purpose of improving clinicians and pharmacists' confidence and familiarity with pharmacogenomics and also to support public understanding and acceptance. The Project will consist of 2 phases. Phase 1 will consist of an appropriately powered patient trial (circa 10,000 to 20,000 patients) at Greater Glasgow and Clyde which must be delivered within 30 months or less from the award date of the contract. Phase 1 will determine the clinical and economic viability of the project. Following completion of Phase 1 the Authority will either: terminate the agreement; extend into Phase 2 with no change to the agreement; Re-negotiate a number of points with the Innovation Partner and enter into Phase 2. Any renegotiation of the Framework Agreement following phase 1 will be in line with Regulation 72 of The Public Contracts (Scotland) Regulations 2015. Phase 2 is the potential widespread adoption of the service across NHS Scotland. The Authority intends to award a framework agreement to one (1) supplier (being the successful tenderer who will become the "Contractor"), however the Authority reserves the right to award a place on the above noted framework agreement to more than one supplier. Full details of the Service can be found within the PIMM documentation which is included in the PQQ/ITT. Additional information: this is an Innovation Partnership Procurement

Renewal: This framework includes the option to extend for up to a total period of thirty (30) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/028052-2024 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Services |
| Procurement method | Selective |
| Procurement method details | Innovation partnership |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 3 Sep 2024 |
| Submission deadline | 5 Jan 2022 |
| Future notice date | Not specified |
| Award date | 3 Sep 2024 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £66,000,000 |
| Lots value | £66,000,000 |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Cancelled |
| Lots status | Cancelled |
| Awards status | Unsuccessful |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## CPV Codes

### Divisions

- 85 - Health and social work services

### Codes

- 85149000 - Pharmacy services

## Release History

- 3 Sep 2024 at 08:54 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/028052-2024
- 29 Nov 2021 at 10:24 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/029545-2021

## Notice URLs

- http://www.nss.nhs.scot/browse/procurement-and-logistics
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000657797
- https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883
- https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02fad8. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-02fad8.json.